Hyderabad: The Drugs Controller General of India (DGCI) has given permission to Bharat Biotech to test its COVID-19 vaccine, COVAXIN, by administering it via the skin.
This intradermal vaccine delivery route is less invasive and will require a lesser dosage as well. The inactive virus-based vaccine is also being tested to be delivered in the intramuscular way.
Currently, the indigenously built vaccine is in phase II trials.
Ahmedabad: Odisha’s Pratyasa Ray made waves on the opening day of the inaugural SFI Short Course Senior National Aquatic Championships in...
Bhubaneswar: A Nowcast warning has been issued for four districts of Odisha. Light rain, with thunder and lightning, are likely...
Bhubaneswar: A Yellow warning has been issued for five Odisha districts over the next two to three hours. Light to...
Moscow: A Russian military aircraft crashed in the far eastern Amur region on Tuesday, killing six people, the country’s Defence...
Copyright © 2026 Frontier Media
